Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4741 (miR-4741) is a small, non-coding RNA molecule involved in the regulation of gene expression at the post-transcriptional level[5]. In human studies, circulating levels of miR-4741 have been identified as independent risk factors and potential protective biomarkers for drug resistance in breast cancer[1]. This microRNA is part of a multi-miRNA signature used for predictive modeling of neoadjuvant chemotherapy response. Its mechanistic role is to bind messenger RNA transcripts and modulate their stability or translation, contributing to the control of cellular proliferation and cancer progression. miR-4741 is not a classical drug target but may serve as a diagnostic marker for patient selection or prognosis in oncology[1][5].
miR-4741 is not a classical pharmacological target; mechanisms involve regulation of mRNA translation and stability, affecting downstream cellular responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4741 (miR-4741 (also MIR4741)).